Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
Clinical trial NCT06066840 · UNKNOWN
Trial details
- NCT number
- NCT06066840
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2025-07-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.